DOCSLIB.ORG

Download the Full PDF Here

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Download the Full PDF Here Oct-Nov-Dec 2015 Volume 16, Issue 4 Targeting Trends Reporting the latest news in Molecular Surgery A specific immunotoxin elucidates a causal role of striatal cholinergic system in behavioral flexibility by Sho Aoki and Jeffery R. Wickens Neurobiology Research Unit, Okinawa Institute of Science and Technology, 1919-1 Tancha, Onna, Kunigami, Okinawa 904-0495, Japan Behavioral flexibility is broadly defined as the ability to change behavioral strategy, Inside this issue: according to a change of governing rules. Accumulated evidence suggests the involvement of particular brain areas such as prefrontal cortex and striatum in this function, in which Targeting Topics Scientific References 3-5 specific brain regions play their own roles. An extension of understanding on neural substrates mediating behavioral flexibility needs a next step beyond the specificity of Targeting Talk brain regions: the specific role of different neuronal subtypes. A method utilizing specific Questions & Answers 5 neurotoxins enabled us to target and elucidate the role of neurochemically-specific Targeting Tools 7 neurons in this ability. In our recent study, 1 we demonstrated a causal role of rat Targeting Teaser cholinergic interneurons in the striatum in behavioral flexibility, using a new specific Word Quiz 8 immunotoxin targeting neurons containing choline acetyltransferase (ChAT). Comparing non-selective neuronal labeling and specific immunostaining of ChAT neurons indicated that local injections of the immunotoxin successfully and selectively damaged cholinergic neurons (Fig. 1). This result is consistent with a previous study that used Anti-ChAT-SAP Highlights to study the medial prefrontal cortex (Cat. #IT-42). 2 ◆ NEW! (pg 2) Using the selective lesion, we compared intact rats injected with saline and rats Mono-Biotin Saporin without cholinergic interneurons of either dorsomedial or ventral striatum in a set-shifting 3 ◆ Teaser Winners (pg 2) task. This task required animals to shift their attention from one stimulus dimension to ◆ Retrograde Transport Suicide Transport and Immunolesioning (pg 5) ◆ Anti-ChAT-SAP. (pg 7) NEW! PACAP-SAP Beta Product ◆ Targeting Teaser (pg 8) Denise Higgins, Editor Fig. 1: Representative coronal sections of the rat striatum show intact nuclei (NeuN) staining but clear ablation of the cholinergic interneurons with ChAT staining in lesioned cases (DMS or VS). Abbreviations; DMS: dorsomedial striatum, VS: ventral striatum, LV: lateral ventricle, CC: corpus callosum, AC, anterior commissure. Scale bar: 1 mm. Reprinted from Aoki et al. (2015). (continued on page 6) Targeting Trends , Page 2 Volume 16, Issue 4 New Product: Mono-Biotin Saporin The conjugation specialists at Advanced Targeting Now, there is Mono-Biotin Saporin , a chemical Systems are proud to announce a new addition to the conjugate between saporin and biotin. Each lot is catalog: specifically manufactured and analyzed to have an Mono-Biotin Saporin average molecular ratio of one biotin per one saporin . Cat. #BT-PR01 The assurance of consistency as well as the controlled labeling potential between lots makes this a valuable new Researchers now have more freedom in selecting research tool. Use this new tool in vitro or in vivo with conjugation strategies. Users have taken advantage of the your targeting agent to broaden your targeted toxin ability to use biotinylated targeting agents with possibilities. 1 Streptavidin-ZAP (Cat. #IT-27) a chemical conjugate between saporin and streptavidin. Streptavidin-ZAP converts biotinylated materials into targeted toxins. Saporin is a ribosome- Streptavidin is a tetrameric protein (molecular weight 53 inactivating protein, molecular kDa in its recombinant form), with each subunit able to weight 30 kDa, from seeds of bind a single biotin molecule. The bond between the plant Saponaria officinalis . streptavidin and biotin is rapid and essentially non- • Saporin is safe for reversible, unaffected by most extremes of pH, organic laboratory use under normal solvents, and denaturing reagents. It is the strongest safety conditions known noncovalent biological interaction • LD 50 in mice is 4 mg/kg (Ka = 10 15 M-1 ) between protein and ligand. The • Saporin does not have a streptavidin used to make Streptavidin-ZAP contains no method of cell entry on its carbohydrate group and has a neutral isoelectric point, own which therefore reduces the nonspecific binding as compared to avidin. A variety of molecules, including lectins, proteins, and antibodies, can be biotinylated and Reference reacted with streptavidin-labeled probes or other Minami SS, Sun B, Popat K, Kauppinen T, Pleiss M, Zhou Y, Ward ME, detection reagents for use in biological assays. Floreancig P, Mucke L, Desai T, Gan L. (2012) Selective targeting of microglia by quantum dots. J Neuroinflammation 9:22. Society for Neuroscience Experimental Biology October 17-21, 2015 April 2-6, 2016 Chicago, IL San Diego, CA Booth #662 Booth #TBA Upcoming Events Targeting Teaser Solution The solution to the puzzle was: Solve this quarter’s teaser at www.ATSbio.com/news/15q4_teaser.html Jumbles: SCLEROTOME CATHETER LUMBAR FLUID Congratulations to the INACTIVATING puzzle solvers from last What the students did when school was out for the summer. quarter. Each winner will receive a $100 Answer: They studied the SCIENCE of VACATION! ATS product credit . LAST QUARTER’S WINNERS: Seto Chice, SUNY HSC at Brooklyn * Corinne Kiessling, Binghamton University, NY Volume 16, Issue 4 Targeting Trends , Page 3 Targeting Topics: Recent Scientific Reference s Reviewed by Matthew Kohls including the mediation of positive and Alterations in the rostral ventromedial negative feedback effects of estradiol on medulla after the selective ablation of luteinizing hormone (LH). In the rat, two mu-opioid receptor expressing kisspeptin neuronal populations exist; one in neurons. the anteroventral periventricular nucleus (AVPV), and the KNDy (kisspeptin/ Harasawa I, Johansen JP, Fields HL, Porreca neurokinin B/dynorphin) neurons in the F, Meng ID. arcuate nucleus. In this work the authors Pain Epub2015. examine the role of KNDy neurons in The rostral ventromedial medulla (RVM) has estradiol positive feedback effects by both excitatory and inhibitory control over administering 10-ng bilateral injections of nociceptive neurons in the medullary dorsal Anti-EFNA4 Calicheamicin NK3-SAP (Cat. #IT-63) into the arcuate horn and spinal cord. Previous work has Conjugates Effectively Target Triple- nucleus of rats. The results indicate that demonstrated that elimination of mu-opioid Negative Breast and Ovarian Tumor- KNDy neurons use dynorphin to inhibit receptor-expressing neurons in the RVM Initiating Cells to Result in Sustained AVPV neurons, establishing a regulatory reduces stress and injury-induced behavioral Tumor Regressions. mechanism for the amplitude of steroid- induced LH surges. hypersensitivity, but the effect of losing Damelin M, Bankovich A, Park A, Aguilar J, these cells on the descending inhibitory Anderson W, Santaguida M, Aujay M, Fong S, Membrane associated cancer-oocyte system has not been examined. The authors Khandke K, Pulito V, Ernstoff E, Escarpe P, neoantigen SAS1B/ovastacin is a administered 1.2 pmol of Dermorphin-SAP Bernstein J, Pysz M, Zhong W, Upeslacis E, Lucas (Cat. #IT-12) to each side of the RVM of candidate immunotherapeutic target J, Lucas J, Nichols T, Loving K, Foord O, Hampl J, for uterine tumors. rats. Saporin (Cat. #PR-01) was used as a Stull R, Barletta F, Falahatpisheh H, Sapra P, Gerber Pires ES, D’Souza RS, Needham MA, Herr control. Characterization of RVM neurons in HP, Dylla SJ. lesioned animals showed a reduction in on- AK, Jazaeri AA, Li H, Stoler MH, Clin Cancer Res 21(18):4165-4173, 2015. and off-cells, but no change in the number of Anderson-Knapp KL, Thomas T, Mandal A, neutral cells. These data indicate that mu- Triple-negative breast cancer (TNBC) is Gougeon A, Flickinger CJ, Bruns DE, Pollok opioid receptor-expressing cells in the RVM characterized by tumors lacking HER2, BA, Herr JC. are not needed for analgesia produced by estrogen receptor, and progesterone receptor. Oncotarget Epub2015. activation of RVM neurons. TNBC has proved to be very difficult to treat, Ovastatin is a zinc matrix metallo-proteinase in large part because of the absence of CD103+ Dendritic Cells Elicit CD8+ T thought to play roles in sperm-egg consensus targets on the surface of the tumor interaction and the prevention of polyspermy Cell Responses to Accelerate Kidney cells. In this work the authors empirically in eutherians. This protein is not found in Injury in Adriamycin Nephropathy. established a set of surface markers normal adult tissues, but is expressed by Cao Q, Lu J, Li Q, Wang C, Wang XM, Lee associated with TNBC tumor initiating cells, uterine carcinosarcomas. The authors VW, Wang C, Nguyen H, Zheng G, Zhao Y, as produced by patient-derived xenografts. investigated the possibility of targeting Alexander SI, Wang Y, Harris DC. Ephrin-A4 was selected as a therapeutic ovastatin as a tumor surface neoantigen for J Am Soc Nephrol Epub2015. target, and a cell line transfected with the therapeutic purposes. SNU539 cells, a ephrin-A4 gene was challenged with two uterine malignant mixed Müllerian tumor- Although it is known that dendritic cells versions of biotinylated anti-ephrin-A4 derived cell line, were challenged with 1 (DCs) are involved in chronic kidney coupled to Streptavidin-ZAP (Cat. #IT-27). μM, 0.1 μM, and 0.01 μM rabbit polyclonal disease, it is not well understood how they Both the mouse monoclonal and the anti-ovastatin coupled to 5.42 nM Fab-ZAP either resolve or aggravate the condition. humanized antibodies reach an EC 50 of rabbit (Cat. #IT-57). Rabbit IgG-SAP (Cat. CD103+ dendritic cells in particular, are 10 ng/ml, indicating that ephrin-A4 has #IT-35) was used as a control. The results known to maintain tolerance through promise as a therapeutic target for TNBC. interaction with regulatory T cells, as well as indicate that for this form of uterine cancer, protect against infection through interactions KNDy neurons modulate the ovastatin is a viable therapeutic target.
Load more

Recommended publications
  • Assessing Neurotoxicity of Drugs of Abuse
    National Institute on Drug Abuse RESEARCH MONOGRAPH SERIES Assessing Neurotoxicity of Drugs of Abuse 136 U.S. Department of Health and Human Services • Public Health Service • National Institutes of Health Assessing Neurotoxicity of Drugs of Abuse Editor: Lynda Erinoff, Ph.D. NIDA Research Monograph 136 1993 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutes of Health National Institute on Drug Abuse 5600 Fishers Lane Rockville, MD 20857 ACKNOWLEDGMENT This monograph is based on the papers and discussions from a technical review on “Assessing Neurotoxicity of Drugs of Abuse” held on May 20-21, 1991, in Bethesda, MD. The technical review was sponsored by the National Institute on Drug Abuse (NIDA). COPYRIGHT STATUS NIDA has obtained permission from the copyright holders to reproduce certain previously published material as noted in the text. Further reproduction of this copyrighted material is permitted only as part of a reprinting of the entire publication or chapter. For any other use, the copyright holder’s permission is required. All other material in this volume except quoted passages from copyrighted sources is in the public domain and may be used or reproduced without permission from the Institute or the authors. Citation of the source is appreciated. Opinions expressed in this volume are those of the authors and do not necessarily reflect the opinions or official policy of the National Institute on Drug Abuse or any other part of the U.S. Department of Health and Human Services. The U.S. Government does not endorse or favor any specific commercial product or company.
    [Show full text]
  • Biosafety Level 1 and Rdna Training
    Biosafety Level 1and rDNA Training Office of Biological Safety Biosafety Level 1 and rDNA Training • Difference between Risk Group and Biosafety Level • NIH and UC policy on recombinant DNA • Work conducted at Biosafety Level 1 • UC Code of Conduct for researchers Biosafety Level 1 and rDNA Training What is the difference between risk group and biosafety level? Risk Groups vs Biosafety Level • Risk Groups: Assigned to infectious organisms by global agencies (NIH, CDC, WHO, etc.) • In US, only assigned to human pathogens (NIH) • Biosafety Level (BSL): How the organisms are managed/contained (increasing levels of protection) Risk Groups vs Biosafety Level • RG1: Not associated with disease in healthy adults (non‐pathogenic E. coli; S. cerevisiae) • RG2: Cause diseases not usually serious and are often treatable (S. aureus; Legionella; Toxoplasma gondii) • RG3: Serious diseases that may be treatable (Y. pestis; B. anthracis; Rickettsia rickettsii; HIV) • RG4: Serious diseases with no treatment/cure (Hemorrhagic fever viruses, e.g., Ebola; no bacteria) Risk Groups vs Biosafety Level • BSL‐1: Usually corresponds to RG1 – Good microbiological technique – No additional safety equipment required for biological work (may still need chemical/radiation protection) – Ability to destroy recombinant organisms (even if they are RG1) Risk Groups vs Biosafety Level • BSL‐2: Same as BSL‐1, PLUS… – Biohazard signs – Protective clothing (lab coat, gloves, eye protection, etc.) – Biosafety cabinet (BSC) for aerosols is recommended but not always required – Negative airflow into room is recommended, but not always required Risk Groups vs Biosafety Level • BSL‐3: Same as BSL‐2, PLUS… – Specialized clothing (respiratory protection, Tyvek, etc.) – Directional air flow is required.
    [Show full text]
  • Biosafety Manual 2017
    Biosafety Manual 2017 Revised 6/2017 Policy Statement It is the policy of Northern Arizona University (NAU) to provide a safe working environment. The primary responsibility for insuring safe conduct and conditions in the laboratory resides with the principal investigator. The Office of Biological Safety is committed to providing up-to-date information, training, and monitoring to the research and biomedical community concerning the safe conduct of biological, recombinant, and acute toxin research and the handling of biological materials in accordance with all pertinent local, state and federal regulations, guidelines, and laws. To that end, this manual is a resource, to be used in conjunction with the CDC and NIH guidelines, the NAU Select Agent Program, Biosafety in Microbiological and Biomedical Laboratories (BMBL), and other resource materials. Introduction This Biological Safety Manual is intended for use as a guidance document for researchers and clinicians who work with biological materials. It should be used in conjunction with the Laboratory-Specific Safety Manual, which provides more general safety information. These manuals describe policies and procedures that are required for the safe conduct of research at NAU. The NAU Personnel Policy on Safety 5.03 also provides guidance for safety in the workplace. Responsibilities In the academic research/teaching setting, the principal investigator (PI) is responsible for ensuring that all members of the laboratory are familiar with safe research practices. In the clinical laboratory setting, the faculty member who supervises the laboratory is responsible for safety practices. Lab managers, supervisors, technicians and others who provide supervisory roles in laboratories and clinical settings are responsible for overseeing the safety practices in laboratories and reporting any problems, accidents, and spills to the appropriate faculty member.
    [Show full text]
  • Biological Safety Guide
    Biological Safety Guide Biological Safety Office Environmental Health & Safety Division 1405 Goss Lane, CI 1001 Augusta, Georgia 30912 Revised: February 2014 STATEMENT OF AUTHORITY Upon publication of these procedures, the Institutional Biosafety Committee (IBC) of the Georgia Regents University, is hereby authorized to act as agent for the Georgia Regents University in matters of review, control, and mediation arising from the use or proposed use of biological materials, including recombinant DNA, at the Georgia Regents University. A statement of composition of the Institutional Biosafety Committee and a delineation of authority is included in the following pages of this text. Furthermore, it is hereby declared that the Biological Safety Office of the Georgia Regents University derives its authority directly from the Office of the President of the Georgia Regents University in all matters involving biological safety and/or violations of accepted rules of practice as described herein. The Biosafety Officer is hereby granted the authority to immediately suspend a project which is found to be a threat to health, property, or the environment. ____________________________________ __________________ James J. Rush, Jr, Esq Date Chief Integrity Officer Georgia Regents University Georgia Regents University Biosafety Guide-January 2012 Statement of Authority TABLE OF CONTENTS List of Abbreviations .............................................................................. viii Forward .................................................................................................
    [Show full text]
  • Alphabetical Listing of Export Restricted Biological Items
    Alphabetical Listing of Export Restricted Biological Items There are two sets of regulations for export restricted biological items, the International Traffic in Arms Regulations (ITAR) from Dept. of State and the Export Administration Regulations from Dept. of Commerce. These items require export licenses to all countries. Licensing takes about 6 weeks. Fines are $250,000 to $1,094,010 per violation. See the Export Control website within the Office of Research at: https://research.uci.edu/ref/export-controls/index.html These listed items are controlled for export regardless of quantity or attenuation, genetic elements or genetically modified organisms for such agents or “toxins”, including small quantities or attenuated strains of select biological agents or “toxins” that are excluded from the lists of select biological agents or “toxins” by APHIS, CDC, or DHHS. Under the ITAR, Biological agents and biologically derived substances specifically developed, configured, adapted, or modified for the purpose of increasing their capability to produce casualties in humans or livestock, degrade equipment or damage crops are controlled under CATEGORY XIV—TOXICOLOGICAL AGENTS, INCLUDING CHEMICAL AGENTS, BIOLOGICAL AGENTS, AND ASSOCIATED EQUIPMENT. Please note that there are proposed regulations on this category that if they become final will impact the listing of biologicals. See Part 121 United States Munitions List Category XIV. Certain precursor chemicals, Biosafety gear, and lab equipment are also export restricted see Categories 1 & 2 of the
    [Show full text]
  • AM 1/06 Mont⁄Ě
    REVIEW ARTICLE PROTEIN BIOTOXINS OF MILITARY SIGNIFICANCE Jiří Patočka1, Ladislav Středa2 University of Defence, Faculty of Military Health Sciences, Czech Republic: Department of Toxicology1; University of South Bohemia, Faculty of Health and Social Studies, Czech Republic: Department of Radiology and Toxicology1; State Office for Nuclear Safety, Czech Republic: Department for Control of the Prohibition of Chemical Weapons2 Summary: There is a spectrum of several threat agents, ranging from nerve agents and mustard agents to natural substan- ces, such as biotoxins and new, synthetic, bioactive molecules produced by the chemical industry, to the classical biologi- cal warfare agents. The new, emerging threat agents are biotoxins produced by animals, plants, fungi, and bacteria. Many types of organisms produce substances that are toxic to humans. Examples of such biotoxins are botulinum toxin, tetanus toxin, and ricin. Several bioactive molecules produced by the pharmaceutical industry can be even more toxic than are the classical chemical warfare agents. Such new agents, like the biotoxins and bioregulators, often are called mid-spectrum agents. The threat to humans from agents developed by modern chemical synthesis and by genetic engineering also must be considered, since such agents may be more toxic or more effective in causing death or incapacitation than classical war- fare agents. By developing effective medical protection and treatment against the most likely chemical and mid-spectrum threat agents, the effects of such agents in a war scenario or following a terrorist attack can be reduced. Toxin-mediated di- seases have made humans ill for millennia. Unfortunately, the use of biological agents as weapons of terror has now been realized, and separating naturally occurring disease from bioterroristic events has become an important public health goal.
    [Show full text]
  • Integrating the Neurobiology of Schizophrenia
    International REVIEW OF Neurobiology Volume 78 International REVIEW OF Neurobiology Volume 78 SERIES EDITORS RONALD J. BRADLEY Department of Psychiatry, College of Medicine The University of Tennessee Health Science Center Memphis, Tennessee, USA R. ADRON HARRIS Waggoner Center for Alcohol and Drug Addiction Research The University of Texas at Austin Austin, Texas, USA PETER JENNER Division of Pharmacology and Therapeutics GKT School of Biomedical Sciences King’s College, London, UK EDITORIAL BOARD ERIC AAMODT HUDA AKIL PHILIPPE ASCHER MATTHEW J. DURING DONARD S. DWYER DAVID FINK MARTIN GIURFA MICHAEL F. GLABUS PAUL GREENGARD BARRY HALLIWELL NOBU HATTORI JON KAAS DARCY KELLEY LEAH KRUBITZER BEAU LOTTO KEVIN MCNAUGHT MICAELA MORELLI JOSE´ A. OBESO JUDITH PRATT CATHY J. PRICE EVAN SNYDER SOLOMON H. SNYDER JOHN WADDINGTON STEPHEN G. WAXMAN Integrating the Neurobiology of Schizophrenia EDITED BY ANISSA ABI-DARGHAM Department of Psychiatry, Columbia College of Physicians and Surgeons New York State Psychiatric Institute Columbia University, New York, USA OLIVIER GUILLIN Unite´ de Psychiatrie CHU ch. Nicolle Rouen, France AMSTERDAM • BOSTON • HEIDELBERG • LONDON NEW YORK • OXFORD • PARIS • SAN DIEGO SAN FRANCISCO • SINGAPORE • SYDNEY • TOKYO Academic Press is an imprint of Elsevier Academic Press is an imprint of Elsevier 525 B Street, Suite 1900, San Diego, California 92101-4495, USA 84 Theobald’s Road, London WC1X 8RR, UK This book is printed on acid-free paper. Copyright ß 2007, Elsevier Inc. All Rights Reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the Publisher.
    [Show full text]
  • Category 1—Page 1
    Commerce Control List Supplement No. 1 to Part 774 Category 1—page 1 CATEGORY 1 - SPECIAL MATERIALS AND to the ITAR” (see 22 CFR parts 120 through RELATED EQUIPMENT, CHEMICALS, 130, including USML Category XXI). (2) “MICROORGANISMS,” AND “TOXINS” See also 1C009. Related Definitions: N/A Note: The Food and Drug Administration Items: (FDA) and the Drug Enforcement Administration (DEA) may control exports of items subject to the a. Seals, gaskets, sealants or fuel bladders, EAR and on the Commerce Control List. BIS “specially designed” for “aircraft” or aerospace provides cross references to these other agency use, made from more than 50% by weight of any controls for convenience only. Therefore, please of the materials controlled by 1C009.b or consult relevant FDA and DEA regulations for 1C009.c; guidance related to the item you wish to export and do not rely solely on the EAR for information b. [Reserved] about other agency export control requirements. See Supplement No. 3 to part 730 (Other U.S. Government Departments and Agencies with 1A002 “Composite” structures or laminates, Export Control Responsibilities) for as follows (see List of Items Controlled). more information. License Requirements A. “END ITEMS,” “EQUIPMENT,” Reason for Control: NS, NP, AT “ACCESSORIES,” “ATTACHMENTS,” “PARTS,” “COMPONENTS,” AND Control(s) Country Chart “SYSTEMS” (See Supp. No. 1 to part 738) 1A001 “Parts” and “components” made from NS applies to entire entry NS Column 2 fluorinated compounds, as follows (see List of NP applies to 1A002.b.1 in NP Column 1 Items Controlled). the form of tubes with an inside diameter between 75 License Requirements mm and 400 mm AT applies to entire entry AT Column 1 Reason for Control: NS, AT Reporting Requirements Country Chart Control(s) (See Supp.
    [Show full text]
  • Bioterrorism
    BIOTERRORISM Edited by Stephen A. Morse Bioterrorism Edited by Stephen A. Morse Published by InTech Janeza Trdine 9, 51000 Rijeka, Croatia Copyright © 2012 InTech All chapters are Open Access distributed under the Creative Commons Attribution 3.0 license, which allows users to download, copy and build upon published articles even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. After this work has been published by InTech, authors have the right to republish it, in whole or part, in any publication of which they are the author, and to make other personal use of the work. Any republication, referencing or personal use of the work must explicitly identify the original source. As for readers, this license allows users to download, copy and build upon published chapters even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. Notice Statements and opinions expressed in the chapters are these of the individual contributors and not necessarily those of the editors or publisher. No responsibility is accepted for the accuracy of information contained in the published chapters. The publisher assumes no responsibility for any damage or injury to persons or property arising out of the use of any materials, instructions, methods or ideas contained in the book. Publishing Process Manager Sasa Leporic Technical Editor Teodora Smiljanic Cover Designer InTech Design Team First published March, 2012 Printed in Croatia A free online edition of this book is available at www.intechopen.com Additional hard copies can be obtained from [email protected] Bioterrorism, Edited by Stephen A.
    [Show full text]
  • Table 4: Protective Action Criteria (PAC) Rev. 29 Based on Applicable
    Table 4: Protective Action Criteria (PAC) Rev. 29a based on applicable 60-minute AEGLs, ERPGs, or TEELs. The chemicals are 3 listed in alphabetical order and the values are presented in mg/m . June 2018 Table 4 is an alphabetical list of the chemical substances and their corresponding PAC values in mass per unit volume (mg/m3). The conversion of ppm to mg/m3 was carried out assuming normal temperature and pressure, 25°C and 760 mm Hg. The columns presented in Table 4 provide the following information: Heading Definition No. The ordered numbering of the chemicals as they appear in this alphabetical listing Chemical Name The name of the chemical substance submitted to the PAC development team CASRN The Chemical Abstracts Service Registry Number1 for this chemical PAC-1 Based on the applicable AEGL-1, ERPG-1, or TEEL-1 value PAC-2 Based on the applicable AEGL-2, ERPG-2, or TEEL-2 value PAC-3 Based on the applicable AEGL-3, ERPG-3, or TEEL-3 value Chemicals for which AEGLs are available have their chemical name, CASRN, and AEGL values displayed in a bolded and larger font. Chemicals for which ERPGs are available, but not AEGLs, have their chemical name, CASRN, and ERPG values displayed in a bolded font. Chemicals for which TEELs are available, but no AEGLs or ERPGs, have their chemical name, CASRN, and values displayed using a regular font. Additional information on PAC values and TEEL values and links to other sources of information is provided on the Subcommittee on Consequence Assessment and Protective Actions (SCAPA) webpage at http://orise.orau.gov/emi/scapa/default.htm.
    [Show full text]
  • AM 1/06 Mont⁄Ì
    REVIEW ARTICLE PROTEIN BIOTOXINS OF MILITARY SIGNIFICANCE Jiří Patočka1, Ladislav Středa2 University of Defence, Faculty of Military Health Sciences, Czech Republic: Department of Toxicology1 and University of South Bohemia, Faculty of Health and Social Studies, Czech Republic: Department of Radiology and Toxicology1 State Office for Nuclear Safety, Czech Republic: Department for Control of the Prohibition of Chemical Weapons2 Summary: There is a spectrum of several threat agents, ranging from nerve agents and mustard agents to natural substan- ces, such as biotoxins and new, synthetic, bioactive molecules produced by the chemical industry, to the classical biologi- cal warfare agents. The new, emerging threat agents are biotoxins produced by animals, plants, fungi, and bacteria. Many types of organisms produce substances that are toxic to humans. Examples of such biotoxins are botulinum toxin, tetanus toxin, and ricin. Several bioactive molecules produced by the pharmaceutical industry can be even more toxic than are the classical chemical warfare agents. Such new agents, like the biotoxins and bioregulators, often are called mid-spectrum agents. The threat to humans from agents developed by modern chemical synthesis and by genetic engineering also must be considered, since such agents may be more toxic or more effective in causing death or incapacitation than classical war- fare agents. By developing effective medical protection and treatment against the most likely chemical and mid-spectrum threat agents, the effects of such agents in a war scenario or following a terrorist attack can be reduced. Toxin-mediated di- seases have made humans ill for millennia. Unfortunately, the use of biological agents as weapons of terror has now been realized, and separating naturally occurring disease from bioterroristic events has become an important public health goal.
    [Show full text]
  • Highly Toxic Ribosome-Inactivating Proteins As Chemical Warfare Or Terrorist Agents
    Mil. Med. Sci. Lett. (Voj. Zdrav. Listy) 2018, 87(4), 158-168 ISSN 0372-7025 (Print) ISSN 2571-113X (Online) DOI: 10.31482/mmsl.2018.027 Since 1925 REVIEW ARTICLE HIGHLY TOXIC RIBOSOME-INACTIVATING PROTEINS AS CHEMICAL WARFARE OR TERRORIST AGENTS Jiri Patocka 1,2 1 Institute of Radiology, Toxicology and Civil Protection, Faculty of Health and Social Studies, University of South Bohemia České Budějovice, České Budějovice, Czech Republic 2 Biomedical Research Centre, University Hospital, Hradec Kralove, Czech Republic Received 20th March 2018. Accepted 24th April 2018. Published 7th December 2018. Summary Biological weapons include infectious agents and toxins. Toxins are poisons produced by living organisms. An important group of toxins are ribosome inactivating proteins (RIPs) of plant or microbial origin that inhibit protein synthesis by inactivating ribosomes. RIPs have been of great scientific interest due to their importance in human health, as both pathogenic agents and therapeutics, but also due to their potential use in biological warfare and bioterrorism. RIPs relevant to bioterrorism include mainly ricin and abrin. Ricin is protein produced in the seeds of the castor oil plant (Ricinus communis). Abrin is protein that has been isolated from the seeds of Abrus precatorius. Both inactivate ribosomes, which results in toxicity because of the inhibition of protein synthesis. Abrin and ricin are substances very toxic to humans in all types of administration, with the exception of oral administration. Symptoms include nausea, diarrhea, tachycardia, hypotension, and seizures. Treatment is supportive, and no antidote exists. Key words: Plant toxic proteins; ribosome inactivating proteins (RIPs); abrin; ricin; modeccin; viscumin; volkensin; warfare; medicine INTRODUCTION Many plants produce proteins that are today referred to as ribosome-inactivating proteins (RIPs) (Stirpe and Battelli, 2006).
    [Show full text]